Non-Hodgkin's Lymphoma Clinical Trials

Showing 1-10 of 10 items
1.
2.
3.
4.
5.
6.
7.
  • DS-3201b in Participants With Lymphomas
  • DS-3201b is an experimental drug. It is not approved for regular use. It can only be used in clinical research. Adults with non-Hodgkin lymphoma (NHL) might be able to join this study if their disease: - has come back after remission - is not responding to current treatment This study has two parts: 1. Dose Escalation is to find the safe dose of DS-3201b that adults with advanced NHL can tolerate. 2. Dose Expansion is to: - find out how effective DS-3201b is for rare types of NHL - collect additional safety data
  • Diagnoses: Non-Hodgkin's Lymphoma
  • Status: Recruiting
8.
9.
10.
Showing 1-10 of 10 items

Know Your Options

Not sure which clinical trials might be right for your child? Email our clinical trials team at clinicaltrials@danafarberbostonchildrens.org.
We can help you navigate your options.

Get Clinical Trial Updates

 

Stay informed about Dana-Farber/Boston Children's research efforts, including information on new and current clinical trials. Sign up to receive our email newsletter Advances in Pediatric Hematology/Oncology.